Cutting-edge heart disease drug to be tested on thousands of UK patients
(Ian Snug/ Nursing Notes) — Inclisiran, a bi-annual injection to lower cholesterol, is set to be studied in UK patients as part of a large-scale NHS clinical trial expected to start later this year.
In a world-first, the drug is expected to be available through a population-level agreement – pioneering a game-changing approach to reducing …